ABMIUM target intelligence
angiotensin I converting enzyme
Angiotensin I converting enzyme (ACE), also known as angiotensin-converting enzyme, ACE1 or CD143, is a peptidase in the renin-angiotensin system. It converts angiotensin I to angiotensin II and inactivates bradykinin, making ACE a central target in blood-pressure, cardiovascular and renal physiology research.
Read full target overviewABMIUM research catalogue
Loading products for ACE…
Research context & evidence
Target information is kept separate from product-level validation so you can review the biology and the reagent evidence independently.
Angiotensin I converting enzyme (ACE; ACE1/CD143) is a peptidase in the renin-angiotensin system that converts angiotensin I to angiotensin II and also inactivates bradykinin, linking it to blood-pressure and fluid-electrolyte regulation.
Angiotensin I converting enzyme (ACE/ACE1/CD143) is studied in renin-angiotensin signalling, cardiovascular biology, renal physiology and blood-pressure regulation. Use the catalogue filters below to compare ABMIUM ACE reagents and confirm product-level suitability before use.
Names used across publications, databases and supplier catalogues.
